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ABSTRACT 
The biogenesis of membrane oligomeric complexes is an intricate process that requires the insertion 
and assembly of transmembrane (TM) domains into the lipid bilayer. The Oxa1p family plays a key 
role in this process in organelles and bacteria. Hell et al. (2001, EMBO J., 20, 1281–1288) recently 
have proposed that Oxa1p could act as part of a general membrane insertion machinery for 
mitochondrial respiratory complex subunits. We have previously shown that mutations in the TM 
domain of Cyt1p can partially compensate for the absence of Oxa1p. Here, we demonstrate that a 
single amino acid substitution in the TM domain of Qcr9p can bypass Oxa1p in yeast. Qcr9p and 
Cyt1p are two subunits of the respiratory complex bc1 and their relative roles in the assembly of 
other respiratory complexes have been investigated. The mutations we have isolated in Cyt1p or 
Qcr9p introduce positively charged amino acids, and we show that the mutant TM domain of Cyt1p 
mediates the restoration of complex assembly. We propose that the positive charges introduced in 
Cyt1p and Qcr9p TM domains promote interactions with negatively charged TM domains of other 
respiratory complex subunits, allowing the coinsertion of both domains into the membrane, in the 
absence of Oxa1p. This model argues in favor of a role of Oxa1p in the insertion and the lateral exit of 
less hydrophobic TM domains from the translocation site into the lipid bilayer. 
 
The biogenesis of membrane oligomeric complexes is an intricate process that requires the 
membrane targeting of subunits, their insertion into the lipid bilayer, folding with cofactors, and the 
assembly into a functional structure. Numerous studies in bacterial or eukaryotic cells have 
demonstrated that most membrane proteins insert at the translocon site and that this process is 
driven by hydrophobic transmembrane (TM) domains (1, 2). However, very little is known about the 
lateral exit of TM domains from the site of insertion into the lipid bilayer and about the mechanistic 
details of subunit assembly into functional complexes. The mitochondrial respiratory chain enzymes 
are complexes composed of numerous nonidentical subunits (Fig. (Fig.1).1). Their biogenesis requires 
the participation of nucleus-encoded factors that are not intrinsic components of the complexes and 
are imported into mitochondria by using a sophisticated translocation machinery (3–5). Most of 
these proteins are conserved through evolution and it has been shown that mutations in the genes 
encoding subunits of the respiratory complexes or assembly assisting proteins are the direct cause of 
several human neurodegenerative pathologies (ref. 6, for review) 
 
Figure 1 
Schematic representation of the mitochondrial respiratory chain. Four respiratory complexes are 
embedded within the inner membrane of mitochondria: the complex I, III or the bc1 complex, IV or 
the cytochrome c oxidase complex (Cox) and the insoluble part of complex V or ATP 
synthase. c represents cytochrome c. bc1 and Cox complexes each contain about 10 subunits. Cyt1p 
and Qcr9p are nucleus-encoded subunits of bc1 complex and have one TM domain each. Cox2p is a 
mitochondria encoded subunit of Cox complex with two TM domains. The small arrows indicate the 
electron (e) flow. 
Oxa1p, a membrane protein conserved from bacteria to eukaryotic organelles, is a key 
component of the insertion machinery of membrane proteins. The Escherichia 
coli homologue YidC interacts with the Sec translocase and mediates the insertion of a subset 
of proteins into the bacterial membrane (7, 8). In yeast mitochondria, the absence of Oxa1p 
leads to a complete loss of respiration associated with severe defects in the insertion and 
assembly of subunits of the Cox and ATPase complexes and with minor defects in the 
assembly of the bc1 complex (9–11). The translocation and maturation of the Cox subunit, 
Cox2p, is almost completely blocked (12, 13) and several other membrane subunits are 
degraded (14). Oxa1p interacts with nascent mitochondrial polypeptides and it has been 
proposed that it could act as part of a general membrane insertion machinery (15). Oxa1p is 
functionally conserved in fission yeast, human and plant mitochondria (16–18) and in 
chloroplasts, its homologue Alb3 plays a role in the insertion of the light harvesting 
chlorophyll-binding proteins into the thylakoid (19, 20). 
The functional conservation of Oxa1p through evolution suggests a crucial role in the 
mechanism of protein insertion into the membrane, but its precise function remains poorly 
understood. Interestingly, we found that its absence in yeast mitochondria can be partially 
compensated for by different mutations. First, ATP synthase assembly and activity is fully 
restored in a strain lacking the mitochondrial protease Yme1p (14). Second, we have isolated 
several suppressor mutations in the TM domain of cytochrome c1 (Cyt1p), an electron carrier 
of the respiratory complex bc1 (21). These mutations partially restore the Cox and ATP 
synthase assembly independently of the electron transfer activity of cytochrome c1, showing 
that the function of Cyt1p revealed by the suppressor mutations is quite distinct from its well-
defined role as an electron carrier. 
In this study, we discovered that a single mutation introducing a positive charge in the TM 
domain of Qcr9p can also partially restore the insertion and assembly of Cox and ATP 
synthase in the absence of Oxa1p. Qcr9p is a bc1 complex subunit and the relative roles of 
Qcr9p and Cyt1p in the assembly of other respiratory complexes have been investigated. 
Although Qcr9p appears dispensable, we found that cytochrome c1 is essential for Cox 
assembly and that its TM domain is essential for the suppression activity. We propose that the 
presence of a positive charge in the TM domain of Qcr9p or Cyt1p promotes interactions with 
a negatively charged TM domain of other respiratory complex subunit, allowing the 
coinsertion of these two TM domains into the lipid bilayer even in absence of Oxa1p. This 
model argues in favor of a role for Oxa1p in the lateral exit of less hydrophobic TM domains, 
e.g., negatively charged TM domains, from their site of translocation within the membrane. 
 
MATERIALS AND METHODS 
Strains, Media, Genetic Methods, and Plasmids. 
All of the strains had the same nuclear background ade2–1 ura3–1 his3–11,-15 trp1–1 leu2–3, 
-112 can1–100. Yeast media, genetic methods, and the strains CW30, NBT2, and R101 were 
described in ref. 21. Ethanol/glycerol medium used was 1% yeast extract, 1% casamino acids, 
0.05 M sodium potassium phosphate (pH 6.25), 3% ethanol, and 3% glycerol. YEpNB33 is a 
multicopy vector and pFL61 is a multicopy yeast expression vector; both carry 
the URA3 gene (21). The double or triple mutant strains were constructed either by 
transformations or genetic crosses between the various single mutants. Strain PHT28 was 
constructed by transforming R102 (see below) with a BstEII/KpnI fragment carrying 
the OXA1 gene and selecting for respiratory competent and uracil prototroph transformants. 
Isolation and Cloning of Suppressor Mutations. 
Genetic suppressors were isolated after UV mutagenesis of the oxa1∷LEU2 (NBT2) 
and oxa1∷URA3 (NBT3) strains (21). Molecular genetics enabled us to map seven of the 
suppressor mutations to the CYT1 gene and four to a distinct locus. To clone this gene, a 
genomic library was constructed from the suppressor strain R102. CsCl-purified nuclear DNA 
was partially digested with HinDIII and ligated with the HinDIII-digested YEpNB33. The 
ligated DNA was used to transform electrocompetent Escherichia coli cells to ampicillin and 
kanamycin resistance. About 380,000 independent transformants were recovered. The library 
DNA was CsCl-purified and used to transform the NBT2 strain. Of 400,000 uracil prototroph 
transformants, 21 were respiratory competent. Plasmids were isolated from these 
transformants and the inserts were characterized. 
Inactivation of the QCR9 Gene: Cloning of the QCR9 cDNA. 
For QCR9 inactivations, the NsiI–PstI fragment of QCR9 was replaced by a 1.5-kb NsiI 
fragment carrying the URA3 gene, or the PCR-amplified G418R cassette (22) was cloned at 
the Klenow-filled NsiI site. The two constructions were used to transform the wild-type strain 
CW30 to give YST1 (qcr9∷URA3) and PHT21 (qcr9∷G418R). Plasmid YEpYS3 carries 
the QCR9 cDNA that was cloned by complementing the PHT21 strain with a yeast cDNA 
library constructed in pFL61. 
Epitope Tagging of Qcr9p. 
We have tagged Qcr9p at its C terminus with 13 c-myc epitopes by using the HIS5 marker 
gene as described (23). DNA was amplified and used to transform to histidine prototrophy 
two yeast strains CW30 and PHT28 carrying the QCR9 or the QCR9–1 allele, respectively. 
Strains YS18–5A, YS16–1B expressing the wild type, or mutant tagged Qcr9p are respiratory 
competent, showing that the tagged proteins are functional. 
Construction of a Short Form of Cyt1p. 
YEpPH225 and YEpYS7 are pFL61-based plasmids expressing either the wild-type CYT1 or 
the CYT1–1 cDNAs. First, a 450-bp AatII/AvaI internal fragment was deleted from 
YEpPH225 and YEpYS7. Then, PvuII–Acc65I-digested plasmids were Klenow-treated and 
self-ligated to give YEpYS12 and YEpYS9. These plasmids enable the expression of a short 
form of pre-Cyt1p protein in which the central hydrophilic region of Cyt1p (175 aa) is deleted 
whereas the first 63 aa are fused in-frame to the last 71 aa (see Fig. Fig.66A). 
 
 
Figure 6 
The mutant membrane domain of Cyt1p mediates suppression. (A) Schematic representation of the 
mutant pre-Cyt1p protein and the short form (see Materials and Methods for constructions). The black 
box represents the hydrophobic domain anchoring the protein to the membrane, and * indicates the 
position of the CYT1–1 mutation. The dashed box represents the 61-aa presequence that is cleaved to 
give the mature form Cyt1p and the four vertical lines indicate the positions of the heme ligands 
within the hydrophilic central domain. (B and C) The Δoxa1 mutant (NBT2) was transformed with 
three plasmids. YEpYS7 expresses the mutant Cyt1p protein (Δoxa1 CYT1–1), pFL61 is the control 
vector (Δoxa1), and YEpYS9 expresses the short form of the mutant Cyt1p (Δoxa1 CYT1–1,-S). (B) 
Transformants were grown on ethanol medium and incubated for a week at 28°C. (C) Mitochondria 
were purified from transformants grown on minimal medium to select for the presence of the plasmid. 
Cox2p, Atp4p, and Atp2p were immunodetected as described in Fig. Fig.22C. 
Isolation of Mitochondria, Carbonate Extraction, and Respiratory Chain 
Activities. 
Mitochondria were purified from cells grown in complete or minimal galactose medium and 
carbonate extractions were performed as in ref. 14. Cytochrome c oxidase activity was 
measured according to ref. 21, ATPase activity according to ref. 24, and ubiquinol 
cytochrome c oxidoreductase activity according to ref. 25. 
Electrophoresis and Immunoblotting. 
They were performed as described (14). The anti-yeast Cox2p was purchased from Molecular 
Probes whereas the anti-Atp2p, anti-Atp4p, and anti-c-myc were generous gifts from J. 
Velours (Institut de Biochimie et Génétique Cellulaire, Bordeaux, France) and J. M. Galan 
(Institut J. Monod, Paris), respectively. 
RESULTS 
A Single Amino Acid Substitution Introducing a Positive Charge in the TM 
Domain of Qcr9p Partially Compensates for the Absence of Oxa1p. 
Yeast is a facultative aerobe organism that can derive energy from fermentation. Yeast cells 
carrying an inactivated Δoxa1 gene are thus viable but respiratory deficient. In consequence, 
they grow on a fermentable substrate such as glucose but are unable to grow on a 
nonfermentable medium containing ethanol or glycerol as respiratory substrate. In the search 
for partners of Oxa1p, we have isolated genetic suppressors that restore the respiratory growth 
of cells in the absence of Oxa1p (Fig. (Fig.22A and Materials and Methods). Among 11 
independent dominant nuclear suppressor mutations, seven mapped to the CYT1 gene (21) and 
four to another gene. To identify this second gene, we constructed a genomic library from the 
strain R102 and used it to transform the Δoxa1 mutant. All of the respiratory-competent 
transformants recovered and harbored the QCR9 gene that encodes a noncatalytic subunit of 
the bc1 complex required for electron transfer activity (26, 27). We have shown that all four 
independent suppressors carry the same single nucleotide substitution (GGT>CGT:QCR9–1) 
at codon 23 of the QCR9 ORF, replacing a glycine residue by an arginine. Qcr9p is a small 
protein composed of 65 aa with a short C-terminal domain located in the intermembrane 
space and a TM domain where the G23K suppressor is located. As a control, we showed that 
overexpression of the wild-type QCR9 gene does not compensate for the absence of Oxa1p, 
demonstrating that the mutation is required for the suppression (data not shown). 
 
 
Figure 2 
The QCR9–1 mutation partially compensates for the respiratory defect caused by the absence of 
Oxa1p. WT (CW30); Δoxa1 (NBT2); Δoxa1 CYT1–1 (R101); Δoxa1 QCR9–1 (R102). See Materials 
and Methods and Hamel et al. (21). (A) Strains were grown on glucose (G) and ethanol/glycerol (E) 
media (see Materials and Methods) and incubated for 7 days at 28°C. (B) The mitochondrial 
translation products were 35S-labeled in vivo in the presence of cycloheximide as described (28). The 
proteins were separated on 16% SDS-polyacrylamide gels. Arrowheads indicate 
apocytochrome b (Cytbp) of bc1 complex, pre-Cox2p, and mature Cox2p of cytochrome c oxidase. 
(C) Mitochondria were purified from cells grown on complete galactose medium as described 
in Materials and Methods. One hundred micrograms of purified mitochondrial proteins was separated 
on 12% SDS-polyacrylamide gels, and the accumulation of Cox2p, Atp4p, and Atp2p subunits was 
analyzed with specific antibodies by Western blotting. Atp2p is used as an internal control as we have 
previously shown that the accumulation of Atp2p does not depend on Oxa1p (14). 
In the absence of Oxa1p, the translocation and maturation of Cox2p is blocked, the assembly 
of Cox and ATP synthase is impaired, and several membrane subunits undergo degradation. 
As shown in Fig. Fig.22 B and C, the QCR9–1 mutation partially restores Cox2p maturation 
and the accumulation of membrane subunits such as Cox2p and Atp4p. Twenty percent of the 
wild-type Cox activity is recovered, and the ATPase oligomycin-sensitive activity is fully 
restored (data not shown). These results indicate that the single glycine to arginine 
substitution in the TM domain of the bc1 complex subunit Qcr9p partially alleviates the 
respiratory complex assembly defects caused by the absence of Oxa1p. Interestingly, Qcr9p 
and Cyt1p are two subunits of the bc1 complex and the QCR9–1 (G23>K) mutation, like 
the CYT1–1 (L216>K) and CYT1–2 (L219>K) mutations, also introduce a positively charged 
amino acid within the TM domain of the protein. 
Interactions Between the TM Domains of Cyt1p and Qcr9p in the Presence of 
Oxa1p. 
According to the crystal structure of beef and Saccharomyces cerevisiae bc1 complexes (29–
30), the two TM domains of Cyt1p and Qcr9p are in close proximity. Thus, we have 
investigated whether functional interactions between the two TM domains could exist and 
their possible implication in respiratory complex assembly. We have compared the effects of 
each single mutation CYT1–1 or QCR9–1 and the combination of both mutations on the 
biogenesis of the bc1, Cox, and ATPase complexes. Although both single mutants show 
substantial respiratory growth, the respiratory growth of the double mutant is strongly 
impaired (Fig. (Fig.33A): its duplication time is about 12 h as compared with 2.5 h for the 
wild type (data not shown). As shown by cytochrome spectra, the amount of 
assembled bc1 complex is decreased in the three strains (Fig. (Fig.33B). The bc1 activity is 
further decreased in the CYT1–1 QCR9–1 double mutant (18% of the wild-type level) 
compared with each single mutant (Table (Table1).1). A slight diminution of Cox activity also 
is observed in the double mutant whereas the QCR9–1 and CYT1–1 mutations alone have no 
detectable effect on this complex. The ATP synthase activity is not affected in any of the 
strains (data not shown). Finally, the activities of the three respiratory complexes are nearly 
nil in the triple mutant Δoxa1 CYT1–1 QCR9–1, several subunits being degraded (data not 
shown). 
 
Figure 3 
Respiratory growth is severely impaired in the double mutant CYT1–1 QCR9–1. WT (CW30); CYT1–
1 (PHT2); QCR9–1 (PHT28); QCR9–1 CYT1–1 (CQ2–2B). (A) Strains were grown on glucose (G) 
and ethanol (E) media as a respiratory substrate and incubated for 3 days at 28°C. (B) Low-
temperature cytochrome absorption spectra of whole cells were recorded according to ref. 9. The 
arrows indicate the absorption maxima of the α bands of cytochromes c (546 nm), c1 (552 nm), b (558 
nm), and a + a3 (602 nm). 
Table 1 
The enzymatic activities of the bc1 and Cox complexes are affected in the double 
mutant CYT1-1 QCR9-1 
Genotype bc1 activity (%) Cox activity (%) 
WT 608  ± 61 (100) 1213  ± 67 (100) 
CYT1-1 456  ± 51 (75) 1310  ± 62 (108) 
QCR9-1 365  ± 55 (60) 1322  ± 50 (109) 
CYT1-1 QCR9-1 109  ± 18 (18) 801  ± 23 (66) 
WT (CW30); CYT1-1 (PHT2); QCR9-1 (PHT28); QCR9-1 CYT1-1 (CQ2-2B). Enzymatic activities were 
measured on mitochondria purified from galactose grown cells as described in Materials and Methods and in 
Fig. Fig.44B. The ubiquinol cytochrome c oxido-reductase activity (bc1 activity) is expressed in nmol of reduced 
cytochrome c/min per mg of protein.  
In conclusion, both the assembly and the enzymatic activities of the bc1 complex are affected 
in the CYT1–1 QCR9–1 double mutant. The two mutations together have a much more 
deleterious effect on the bc1 complex activity than each single mutation. Also a slight 
decrease in the Cox activity is only visible in the double mutant. Thus, the two TM domains 
of Cyt1p and Qcr9p seem to genetically interact and this interaction appears critical for the 
assembly and/or activity of bc1 and Cox complexes. 
Cyt1p Is Required for the Restoration of Cox Assembly in Absence of Oxa1p. 
Mutations in the TM domains of Cyt1p and Qcr9p partially restore the insertion and assembly 
of Cox and ATP synthase in the absence of Oxa1p. However, this restoration is always 
stronger with the CYT1–1 than with the QCR9–1 mutation (Fig. (Fig.2).2). To establish the 
relative role of these two subunits in the restoration of respiratory complex assembly, we 
asked whether either of the suppressor mutations could function in the absence of the other 
subunit. 
We constructed two Δoxa1 strains carrying either the CYT1–1 mutation and 
the Δqcr9 inactivation, or the QCR9–1 mutation and the Δcyt1 inactivation. As the two 
subunits Cyt1p and Qcr9p are required for the bc1 electron transfer activity, this activity is nil 
in the two strains and we found that the ATPase activity is still fully restored (data not 
shown). As shown in Fig. Fig.44 A and B, Cox2p maturation and Cox activity are still 
partially restored in the strain carrying the CYT1–1 mutation and the Δqcr9 inactivation, 
whereas no restoration is detected in the strain carrying the QCR9–1 mutation and 
the Δcyt1 inactivation. We have ruled out the possibility that the Cox deficiency in the latter 
strain is caused by the destabilization of Qcr9p in the absence of Cyt1p (Fig. (Fig.44C). 
Moreover, carbonate extractions show that Qcr9p is found predominantly in the membrane 
fraction in both strains (data not shown). Thus, the lack of restoration of Cox assembly 
observed in the Δcyt1 QCR9–1 strain is not caused by the destabilization or mislocalization of 
Qcr9p but is more likely to be caused by the absence of Cyt1p. Hence, Cyt1p is required for 
the restoration of Cox assembly by the QCR9–1 mutation whereas Qcr9p is not necessary for 
this restoration by the CYT1–1 mutation. Thus, Cyt1p has a major role in the restoration of 
Cox assembly in the absence of Oxa1p. 
 
Figure 4 
Cyt1p is essential for the restoration of Cox assembly in the absence of Oxa1p. (A) Mitochondrial 
translation products were labeled as described in Fig. Fig.22B. WT (CW30); Δoxa1 CYT1–1 
Δqcr9 (YST3); Δoxa1 Δcyt1 QCR9–1 (YST4); Δcyt1 QCR9–1 (YSG9–3B). (B) Enzymatic activities 
were measured in mitochondria purified from galactose grown cells as described in Materials and 
Methods. The cytochrome c oxidase activity (Cox activity) is expressed in nmol of oxidized 
cytochrome c/min per mg of protein and percentages of wild-type activities are given in parenthesis. 
(C) Qcr9p was tagged with the c-myc epitope as described in Materials and Methods. Five hundred 
micrograms of total yeast proteins, extracted as described (31), was separated on 12% SDS-
polyacrylamide gels and immunoblotted with anti-c-myc. WT (YS18–5A), QCR9–1 (YS16–
1B), Δoxa1 QCR9–1 (YS16–18D), Δoxa1 Δcyt1 QCR9–1 (YS16–1C). 
The Mutant TM Domain of Cyt1p Mediates the Restoration of Complex 
Assembly. 
Cyt1p has a bipartite structure. A large N-terminal hydrophilic domain, located in the 
intermembrane space and binding the heme moiety, is responsible for the electron transfer 
activity. A short C-terminal hydrophobic domain anchors the molecule to the mitochondrial 
inner membrane (refs. 32 and 33 for reviews). As shown in Fig. Fig.5,5, Cyt1p is tightly 
bound to the membrane and resistant to carbonate extraction in wild-type cells. However, fast-
migrating carbonate-extractable forms of cytochrome c1 are systematically observed in 
the Δoxa1 CYT1–1 strain, and we have previously proposed that they could be responsible for 
the restoration of complex assembly (21). In the Δoxa1 QCR9–1 strain, no carbonate 
extractable forms of cytochrome c1 are detected. This finding indicates that these forms do 
not play a major role in suppression but are likely to be a simple consequence of the CYT1–
1 mutation. Indeed, this mutation introduces a positive charge in the TM and thus probably 
modifies the binding properties of Cyt1p to the membrane. Furthermore, the nature and 
position of all of the suppressor mutations in the TM domains of Cyt1p and Qcr9p suggests 
that the TM domain of Cyt1p is responsible for the restoration of complex assembly. 
 
 
Figure 5 
Carbonate-extractable forms of cytochrome c1 do not accumulate in the Δoxa1 QCR9–1 strain. 
Mitochondria (equivalent of 300 μg of proteins) were purified from cells grown on galactose complete 
medium and treated with sodium carbonate as described (14). The supernatants (S; soluble fractions) 
and pellets (P, membrane fractions) were separated on 12.5% SDS-polyacrylamide gels and 
transferred to nitrocellulose filters. Detection of cytochromes c and c1 was performed on the 
membrane as described (34). * indicates the fast-migrating extractable forms of cytochrome c1. WT 
(CW30); Δoxa1 QCR9–1 (R102); Δoxa1 CYT1–1 (R101). 
To test this hypothesis, we constructed a shortened Cyt1p (see Materials and Methods) that no 
longer carries the hydrophilic domain of Cyt1p but only encodes the presequence essential for 
the correct mitochondrial import and the C-terminal part of the protein with the mutant TM 
domain (Fig. (Fig.66A). Remarkably, the respiratory growth is restored by the short Cyt1p in 
cells carrying an inactivated Δoxa1 gene together with a wild-type CYT1 gene ensuring full 
electron transfer activity through the bc1 complex. We found that Cox2p accumulation and 
Cox activity are still partially recovered whereas the accumulation of Atp4p and ATPase 
activity are restored to wild-type level (Fig. (Fig.66 B and C, and data not shown). However, 
the restoration mediated by the short Cyt1p does not take place in the absence of wild-type 
Cyt1p or Qcr9p (data not shown). This finding suggests that this short mutant Cyt1p requires 
the presence of some assembled bc1 complex, which may be necessary for the correct 
integration or orientation of the proteins in the membrane. In addition, a short form of Cyt1p 
with a wild-type TM domain is able to restore neither the respiratory growth nor the complex 
assembly, stressing the importance of the CYT1–1 mutation in the mechanism of suppression 
(data not shown). In conclusion, the mutant TM domain of cytochrome c1 restores the 
assembly of both Cox and ATPase complexes in the absence of Oxa1p. 
DISCUSSION 
The Oxa1p family plays a pivotal role in the insertion and assembly of membrane proteins 
into organelles and bacteria. In yeast mitochondria, the absence of Oxa1p leads to severe 
defects in the biogenesis of the Cox and ATPase complexes and to minor defects in the 
assembly of the bc1 complex. Unexpectedly, we have shown that single mutations in the TM 
domains of two subunits of the bc1 complex, Cyt1p and Qcr9p, can bypass the absence of 
Oxa1p and partially restore the biogenesis of Cox and ATPase assembly (ref. 21 and this 
study). This restoration is independent of the electron transfer activity of the bc1 complex 
because we have shown that it also occurs in strains deficient for the bc1 complex activity 
(see Fig. Fig.44). 
Introduction of a Positive Charge in TM Domains of Either of the 
Two bc1 Subunits Restores the Insertion and Assembly of Cox and ATPase 
Complexes. 
In most cases, the mutations in Cyt1p or Qcr9p that compensate for the absence of Oxa1p 
correspond to single amino acid substitutions. For Cyt1p, these mutations affect a number of 
amino acids all located in the TM domain, e.g., the CYT1–1 or CYT1–2 mutations that change 
the leucine 216 or 219 to a lysine residue (21). In this study, we show that the mutant TM 
domain of Cyt1p is sufficient on its own for the restoration of complex assembly. For Qcr9p, 
we have obtained in all four cases, the same substitution changing the glycine 23 to an 
arginine residue (mutation QCR9–1). This glycine, located in the middle of the TM domain, is 
conserved in the plant, chicken, and mammal homologues and may play an important role in 
complex assembly. 
According to the crystal structure of the yeast bc1 complex (30, 33), the TM domains of 
Cyt1p and Qcr9p are in close proximity and our studies on the double mutant CYT1–1 QCR9–
1 show that these two domains interact genetically. Moreover, Cyt1p seems to be absolutely 
required for the restoration of Cox assembly by the mutant Qcr9p, this restoration being in 
any case weaker than with the mutant Cyt1p itself. Thus, the QCR9–1 mutation seems to act 
with Cyt1p, at least for restoration of Cox assembly, and glycine 23 appears critical for the 
interactions between Qcr9p and Cyt1p. The full restoration of ATPase assembly by 
the QCR9–1 mutation in the absence of Cyt1p is reminiscent of restoration observed in the 
protease-deficient mitochondria (14) and suggests that the need of Oxa1p for ATPase 
assembly is slight enough to be bypassed by a number of extragenic mutations. 
Restoration of Complex Assembly Could Occur Through Lateral Interactions 
Between TM Domains of Various Subunits. 
It recently was shown that the yeast and mammalian respiratory complexes assemble into 
supramolecular structures (35, 36). In particular, the bc1 and Cox complexes associate to form 
a supercomplex and the subunits Qcr9p and Cyt1p both appear important for its formation. 
We have shown that the double mutation CYT1–1 QCR9–1 not only drastically reduces 
the bc1 complex activity but also noticeably affects Cox activity. This result together with the 
fact that the Cyt1p and Qcr9p TM domains are located at the periphery of the bc1 complex 
(30) suggest that these domains could interact with Cox subunits during the biogenesis of the 
complexes. 
QCR9–1 and the mutations in the Cyt1p TM domain that compensate for the absence of 
Oxa1p introduce positively charged amino acids in the membrane region. Thus it is tempting 
to propose that this charge is responsible for the restoration of respiratory complex assembly. 
This positively charged amino acid could interact with a negatively charged amino acid of 
another TM domain. Such negatively charged amino acids occur in several TM domains of 
respiratory complex subunits. In particular, an analysis of the crystal structure of beef Cox 
complex (37) and sequence alignments between beef and yeast subunits indicates that the 
beginning of the first TM helix of Cox2p presents several acidic amino acids. Indeed, one of 
the main consequence of the absence of Oxa1p is a defect of Cox2p insertion and 
translocation (12, 13). Thus, it is tempting to propose that the negatively charged residues of 
Cox2p could interact with the positive charge present in the mutant TM of Cyt1p or Qcr9p, 
this interaction leading to the restoration of Cox2p insertion. 
Oxa1p Could Play a Role in the Insertion and Lateral Exit of Less Hydrophobic 
TM Domains. 
How could such simple membrane interactions bypass the need for Oxa1p, which has been 
proposed to be essential for the insertion within the inner membrane of respiratory complex 
subunits? It has been recently shown that the insertion of some membrane subunits, such as 
Atp9p and Atp8p subunits, is completely Oxa1p-independent (14, 38). Similarly, substantial 
assembly of the bc1 complex subunits can occur in the absence of Oxa1p (9). Samuelson et 
al. (7) and Scotti et al. (8) have proposed that the bacterial Oxa1p homologue, YidC, could 
act like the TRAM protein of the mammalian endoplasmic reticulum membrane. TRAM 
appears to be required for the insertion and lateral exit of TM segments that are not 
sufficiently hydrophobic to equilibrate by themselves into the lipid bilayer, these less 
hydrophobic sequences being sandwiched between the multispanning TRAM protein (39, 40). 
Oxa1p has five predicted TM segments and may play a similar role in the inner membrane of 
mitochondria for the less hydrophobic TM segments, such as the first TM helix of Cox2p (see 
Fig. Fig.7).7). If this model is true, one can predict that the introduction of charged residue in 
a TM domain would render it more dependent on Oxa1p. This is the case for the TM domain 
of Cyt1p for which the presence of a positive charge (e.g., CYT1–1) leads to the accumulation 
of noninserted (carbonate extractable) forms of Cyt1p in the Δoxa1 mutant, the insertion of 
wild-type Cyt1p being Oxa1p-independent. In the absence of Oxa1p and in the presence of 
mutant TM domain of either Qcr9p or Cyt1p, we propose that the positively charged TM 
domains of the bc1 complex subunit can interact with the negatively charged TM domain of 
Cox2p or other Oxa1p-dependent subunits. This interaction could allow some lateral exit of 
the TM domain within the lipid bilayer from their site of insertion, leading to partial 
restoration of respiratory complex assembly even when Oxa1p is not present. The insertion of 
less hydrophobic TM domain might play an essential role for the formation of oligomeric 
membrane complexes because the charged residues located in the TM domain are likely to be 
important for the folding and stabilization of the complex structure. 
 
Figure 7 
Mode of action of Oxa1p and positively charged TM domains. (A) Oxa1p could allow the membrane 
insertion of charged or less hydrophobic TM domains (e.g., first TM helix of Cox2p) by sandwiching 
them until they reach stable integration within the oligomeric complex (Cox complex). (B) Positively 
charged TM domain (e.g., Cyt1p) could be coinserted with a negatively charged one (e.g., first TM 
helix of Cox2p). 
Several additional proteins might be also involved in the translocation/insertion machinery of 
mitochondrial membrane proteins (41–44). In particular, Preuss et al. (44) have shown that 
the double mutant Δmba1 Δoxa1 exhibits a strong growth defect even on glucose, suggesting 
that Oxa1p and Mba1p have an important overlapping function. However, the fact that 
the CYT1–1 mutation does not suppress the double mutant Δmba1 Δoxa1 (data not shown) 
suggests that Mba1p acts at a different step of the translocation machinery. This work 
provides a genetic demonstration that the TM domain of subunits of different complexes 
interact during the biogenesis and reinforces the recent view that respiratory enzymes are 
assembled into supramolecular structures (35, 36). 
ACKNOWLEDGMENTS 
We thank N. Lachacinsky for technical assistance. We thank Dr. J. Herrmann (Institute for 
Physiological Chemistry, Munich) for the mba1 mutant and Drs. J. Velours and J. M. Galan 
for the gift of antisera. We are grateful to Drs. N. Bonnefoy, O. Groudinsky, and C. J. Herbert 
for discussions and critical reading of the manuscript and C. J. Herbert for checking the 
English. This work was supported in part by a grant from the Association Française contre les 
Myopathies and by a fellowship from Ligue contre le Cancer de l'Essonne (to P.H.). 
 
 
REFERENCES 
1. de Gier J-W, Luirink J. Mol Microbiol. 2001;40:314–322. [PubMed] [Google Scholar] 
2. Rapoport T A, Jungnickel B, Kutay U. Annu Rev Biochem. 1996;65:271–303. [PubMed] [Google 
Scholar] 
3. Grivell L A. Crit Rev Biochem Mol Biol. 1995;30:121–164. [PubMed] [Google Scholar] 
4. Herrmann J, Neupert W. Curr Opin Microbiol. 2000;3:210–214. [PubMed] [Google Scholar] 
5. Tokatlidis K, Schatz G. J Biol Chem. 1999;274:35285–35288. [PubMed] [Google Scholar] 
6. Sue C M, Schon E A. Brain Pathol. 2000;10:442–450. [PubMed] [Google Scholar] 
7. Samuelson J C, Chen M, Jiang F, Moller I, Wiedmann M, Kuhn A, Phillips G J, Dalbey R E. Nature 
(London) 2000;406:637–641. [PubMed] [Google Scholar] 
8. Scotti P A, Urbanus M L, Brunner J, de Gier J-W L, von Heijne G, van der Does C, Driessen A J M, 
Oudega B, Luirink J. EMBO J. 2000;19:542–549. [PMC free article] [PubMed] [Google Scholar] 
9. Bonnefoy N, Chalvet F, Hamel P, Slonimski P P, Dujardin G. J Mol Biol. 1994;239:201–
212. [PubMed] [Google Scholar] 
10. Bauer M, Behrens M, Esser K, Michaelis G, Pratje E. Mol Gen Genet. 1994;245:272–
278. [PubMed] [Google Scholar] 
11. Altamura N, Capitanio N, Bonnefoy N, Papa S, Dujardin G. FEBS Lett. 1996;382:111–
115. [PubMed] [Google Scholar] 
12. Hell K, Herrman J, Pratje E, Neupert W, Stuart R A. Proc Natl Acad Sci USA. 1998;95:2250–
2255. [PMC free article] [PubMed] [Google Scholar] 
13. He S, Fox T D. Mol Biol Cell. 1997;8:1449–1460. [PMC free article] [PubMed] [Google Scholar] 
14. Lemaire C, Hamel P, Velours J, Dujardin G. J Biol Chem. 2000;275:23471–
23475. [PubMed] [Google Scholar] 
15. Hell K, Neupert W, Stuart R A. EMBO J. 2001;20:1281–1288. [PMC free article] [PubMed] [Google 
Scholar] 
16. Bonnefoy N, Kermorgant M, Groudinsky O, Dujardin G. Mol Microbiol. 2000;35:1135–
1145. [PubMed] [Google Scholar] 
17. Bonnefoy N, Kermorgant M, Groudinsky O, Minet M, Slonimski P P, Dujardin G. Proc Natl Acad Sci 
USA. 1994;91:11978–11982. [PMC free article] [PubMed] [Google Scholar] 
18. Hamel P, Sakamoto W, Wintz H, Dujardin G. Plant J. 1997;12:101–109. [Google Scholar] 
19. Sundberg E, Slagter J G, Friborg I, Cleary S P, Robinson C, Coupland G. Plant Cell. 1997;9:717–
730. [PMC free article] [PubMed] [Google Scholar] 
20. Moore M, Harrison M S, Peterson E C, Henry R. J Biol Chem. 2000;275:1529–
1532. [PubMed] [Google Scholar] 
21. Hamel P, Lemaire C, Bonnefoy N, Brivet-Chevillotte P, Dujardin G. Genetics. 1998;150:601–
611. [PMC free article] [PubMed] [Google Scholar] 
22. Wach A, Brachat A, Pohlmann R, Philippsen P. Yeast. 1994;10:1793–1808. [PubMed] [Google 
Scholar] 
23. Longtine M S, McKenzie A, III, Demarini D J, Shah N G, Wach A, Brachat A, Philippsen P, Pringle J 
R. Yeast. 1998;14:953–961. [PubMed] [Google Scholar] 
24. Spannagel C, Vaillier J, Chaignepain S, Velours J. Biochemistry. 1998;37:615–
621. [PubMed] [Google Scholar] 
25. Brasseur G, Coppée J, Colson A-M, Brivet-Chevillotte P. J Biol Chem. 1995;270:29356–
29364. [PubMed] [Google Scholar] 
26. Phillips J D, Schmitt M E, Brown T A, Beckmann J D, Trumpower B L. J Biol 
Chem. 1990;265:20813–20821. [PubMed] [Google Scholar] 
27. Graham L A, Phillips J D, Trumpower B L. FEBS Lett. 1992;313:251–254. [PubMed] [Google 
Scholar] 
28. van Dyck L, Neupert W, Langer T. Genes Dev. 1998;12:1515–1524. [PMC free 
article] [PubMed] [Google Scholar] 
29. Xia D, Yu C-A, Kim H, Xia J-Z, Kachurin A M, Zhang L, Yu L, Deinsenhofer J. Science. 1997;277:60–
66. [PubMed] [Google Scholar] 
30. Hunte C, Koepke J, Lange C, Rossmanith T, Michel H. Structure (London) 2000;8:669–
684. [PubMed] [Google Scholar] 
31. Yaffe M P. Methods Enzymol. 1991;194:627–643. [PubMed] [Google Scholar] 
32. Trumpower B. Microbiol Rev. 1990;54:101–129. [PMC free article] [PubMed] [Google Scholar] 
33. Berry E, Guergova-Kuras M, Huand L, Crofts A. Annu Rev Biochem. 2000;69:1005–
1075. [PubMed] [Google Scholar] 
34. Vargas C, McEwan A G, Downie J A. Anal Biochem. 1993;209:323–326. [PubMed] [Google Scholar] 
35. Schagger H, Pfeiffer K. EMBO J. 2000;19:1777–1783. [PMC free article] [PubMed] [Google 
Scholar] 
36. Cruciat C-M, Brunner S, Baumann F, Neupert W, Stuart R A. J Biol Chem. 2000;275:18093–
18098. [PubMed] [Google Scholar] 
37. Tsukihara T, Aoyama H, Yamashita E, Tomizaki T, Yamaguchi H, Shinzawa-Itoh K, Nakashima R, 
Yaono R, Yoshikawa S. Science. 1996;272:1136–1144. [PubMed] [Google Scholar] 
38. Li M, Mihara K. J Biol Chem. 2001;276:24704–24712. [PubMed] [Google Scholar] 
39. Matlack K E S, Mothes W, Rapoport T A. Cell. 1998;92:381–390. [PubMed] [Google Scholar] 
40. Heinrich S U, Mothes W, Brunner J, Rapoport T A. Cell. 2000;102:233–244. [PubMed] [Google 
Scholar] 
41. Rep M, Nooy J, Guelin E, Grivell L A. Curr Genet. 1996;30:206–211. [PubMed] [Google Scholar] 
42. He S, Fox T D. Mol Cell Biol. 1999;19:6598–6607. [PMC free article] [PubMed] [Google Scholar] 
43. Souza R L, Green-Willms N S, Fox T D, Tzagoloff A, Nobrega F G. J Biol Chem. 2000;275:14898–
14902. [PubMed] [Google Scholar] 
44. Preuss M, Leonhard K, Hell K, Stuart R A, Neupert W, Herrmann J M. J Cell Biol. 2001;153:1085–
1095. [PMC free article] [PubMed] [Google Scholar] 
 
